Is Zomig a Controlled Substance?
No, Zomig (zolmitriptan) is not a controlled substance. It is a prescription medication classified as a triptan (5-HT1B/1D receptor agonist) used for acute migraine treatment, but it has no abuse potential and is not scheduled under the Controlled Substances Act 1.
Key Points About Zomig's Classification
- Prescription status: Zomig requires a prescription but is not subject to DEA scheduling or controlled substance regulations
- Drug class: Selective serotonin 5-HT1B/1D receptor agonist (triptan family)
- Available formulations: Oral tablets (2.5 mg, 5 mg), orally disintegrating tablets, and nasal spray (2.5 mg, 5 mg) 1
Clinical Context
Zomig is recommended as a first-line treatment for moderate to severe acute migraine attacks. Current guidelines recommend adding a triptan (including zolmitriptan/Zomig) to an NSAID or acetaminophen when adequate doses of these medications alone do not provide sufficient pain relief 2. The choice of specific triptan should be based on individualized factors including route of administration preference and cost 2.
Important Prescribing Considerations
While not controlled, Zomig does have important prescribing restrictions:
- Contraindications: Uncontrolled hypertension, cardiovascular disease, cerebrovascular disease 1
- Medication overuse headache risk: Using acute migraine medications (including triptans) on ≥10 days per month can lead to medication overuse headache 2, 1
- Serotonin syndrome risk: When combined with SSRIs, SNRIs, TCAs, or MAO inhibitors 1
The medication can be prescribed and refilled like any other non-controlled prescription medication, without the additional documentation, storage, or dispensing requirements that apply to controlled substances.